|
OmniComm Ranks Number 284 on Deloitte’s 2009 Technology Fast 500TM for Fastest
Growing Companies in North America.
Attributes its 455% Percent Revenue Growth to the superiority of its Electronic Data
Capture (EDC) solution TrialMasterTM and its "First in Customer Service”
philosophy.
Fort Lauderdale, FL, October 20, 2009 - OmniComm Systems,
Inc. (OTC: OMCM.OB)today announced that it ranked number 284 on
Technology Fast 500™, Deloitte LLP’s ranking of 500 of the fastest growing technology,
media, telecommunications, life sciences and clean technology companies in North
America. Rankings are based on percentage of fiscal year revenue growth during the
five-year period from 2004–2008. OmniComm grew 455% percent during this period.
OmniComm’s CEO, Cornelis F. Wit, credits the company’s flagship product TrialMasterTM,
and the fact that it was built to the exacting specifications required by the Lifescience
industry, for the company’s 455% revenue growth over the past five years. "We are
very pleased to be ranked on the Technology Fast 500 list for the second time in
the past 5 years", Mr. Wit said. "This is a testament to the quality of our TrialMaster
solution and it illustrates the commitment and vision towards superior customer
service embraced by the company as a whole. At OmniComm, we are looking forward
to continuing to serve the Lifescience industry with innovative and flexible EDC
solutions in their quest for lifesaving therapies and devices." Mr. Wit added, "The
recent additions to our product portfolio of complementary eClinical solutions speaks
volumes about our commitment to the industry. We’re not just an EDC shop; we provide
a whole array of eClinical solutions and services to our customers."
"Technology Fast 500TM recognizes innovative companies that have broken
down barriers to success and defied the odds with their remarkable five-year revenue
growth," said Phil Asmundson, Vice Chairman and U.S. Technology, Media and Telecommunications
leader, Deloitte LLP. "We congratulate OmniComm on this accomplishment."
"With its impressive five-year growth, OmniComm has earned its position among the
fastest growing technology, media, telecommunications, life sciences and clean technology
companies in North America," said Mark Jensen, Managing Partner, Technology and
Venture Capital Services, Deloitte & Touche LLP. "Deloitte is proud to honor OmniComm
for its achievement."
OmniComm previously ranked 140th as a Technology Fast 500TM award winner for 2005.
Overall, Technology Fast 500TM award winners for 2009 had growth rates
ranging from 212 to 146,050 percent over five years, with an average growth rate
of 2,486 percent.
Technology Fast 500TM Selection and Qualifying Criteria
Technology Fast 500TM provides a ranking of the fastest growing technology, media,
telecommunications, life sciences and clean technology companies in North America.
This ranking is compiled from nominations submitted directly to the Technology Fast
500TM website, and public company database research conducted by Deloitte. Technology
Fast 500TM award winners for 2009 are selected based on percentage fiscal year revenue
growth during the five-year period from 2004 to 2008. In order to be eligible for
Technology Fast 500TM recognition, companies must own proprietary intellectual property
or proprietary technology that contributes to a significant portion of the company's
operating revenues. Using other companies' technology or intellectual property in
a unique way does not satisfy this requirement. Consulting companies, professional
service firms, etc. are not eligible unless they have proprietary technology that
contributes to a significant portion of their operating revenues. Technology Fast
500TM award eligibility requirements also include base-year operating revenues of
at least $50,000 USD or CD, and current-year operating revenues of at least $5 million
USD or CD. These revenues must have more than doubled between 2004 and 2008. Additionally,
companies must be in business for a minimum of five years, and be headquartered within North America.
About OmniComm
OmniComm Systems, Inc. (www.OmniComm.com)
provides customer-driven Internet solutions to pharmaceutical, biotechnology, research
and medical device organizations that conduct life changing clinical trial research.
OmniComm's growing base of satisfied customers is a direct result of the company's
commitment to deliver products and services that ensure ease of use, faster study
build, ease of integration and better performance. OmniComm's client intuitive pricing
model allows companies that range from small, to mid-size to large scale institutions
to safely and efficiently capitalize on their clinical research investments. OmniComm
Systems, Inc has U.S. headquarters in Fort Lauderdale, FL and European headquarters
in Bonn, Germany, with satellite offices in New Jersey, the United Kingdom, and
Russia as well as sales offices throughout the U.S. and Europe.
About Deloitte
"As used in this document, "Deloitte" means Deloitte LLP. Please see www.deloitte.com/about for a detailed description of the
legal structure of Deloitte LLP and its subsidiaries."
Safe Harbor Disclaimer
Safe Harbor Disclaimer Statements made by OmniComm included in this release may
constitute forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties
such as the Company's ability to obtain new contracts and accurately estimate net
revenues due to uncertain regulatory guidance, variability in size, scope and duration
of projects, and internal issues at the sponsoring client, integration of acquisitions,
competitive factors, technological development, and market demand. As a result,
actual results may differ materially from any financial outlooks stated herein.
Further information on potential factors that could affect the Company's financial
results can be found in the Company's Reports on Form 10-K and 10-Q filed with the
Securities and Exchange Commission. The Company undertakes no obligation to publicly
update any forward-looking statement, whether as a result of new information, future
events, or otherwise.
CONTACT: Stephen Johnson at: + 1 954-377-1726
Back
|
